Biography
- Dr. Schulz graduated from Hunter College of the City University of New York with a B.A. in Psychology and received his Ph.D. in Neuropsychology from the Graduate Center of the City University of New York. His graduate research focused on the neurochemical and neuroendocrine bases of childhood disruptive behavior disorders. Dr. Schulz was subsequently appointed to a postdoctoral fellowship on a NIMH-funded Interdisciplinary Research Network on Attention-Deficit/Hyperactivity Disorder (ADHD) and completed two years of training in functional neuroimaging under the mentorship of Drs. Jin Fan, Jeffrey Newcorn, and Jeffrey Halperin.
Research
Research
Dr. Schulz is currently an Assistant Professor in the Department of Psychiatry at The Mount Sinai School of Medicine in New York. He has been using functional magnetic imaging resonance (fMRI) techniques to investigate self-regulatory mechanisms in children and adolescents with ADHD, as well as the effects of pharmacological treatments on these mechanisms. Dr. Schulz's main research interest lies in understanding the neurobiological mechanisms responsible for the developmental change, remission, and escalation of symptomatology commonly seen in childhood psychiatric disorders.
Clinical Interests:
Attention-Deficit/Hyperactivity Disorder
Disruptive Behavior Disorders
Aggressive behavior
Brain development
Languages: English, German
Publications
Solanto MV, Schulz KP, Fan J, Tang CY, Newcorn JH. Functional MRI in Predominantly Inattentive and Combined Subtypes of ADHD. Journal of Neuroimaging 2008;.
Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with ADHD. Archives of General Psychiatry 2007; 64(8): 932-940.
Marks DJ, Miller SR, Schulz KP, Newcorn JH, Halperin JM. The interaction of psychosocial adversity and biological risk in childhood aggression. Psychiatry Research 2007; 151: 221-230.
Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM, Schulz K, Pradhan K. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007; 34(3): 1182-1190.
Halperin JM, Kalmar JH, Schulz KP, Marks DJ, Sharma V, Newcorn JH. Elevated childhood serotonergic function protects against adolescent aggression in disruptive boys. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45: 833-840.
Halperin JM, Schulz KP. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder (ADHD). Psychological Bulletin 2006; 132: 560-581.
Schulz KP, Tang CY, Fan J, Marks DJ, Cheung AM, Newcorn JH, Halperin JM. Differential prefrontal cortex activation during inhibitory control in adolescents with and without childhood ADHD. Neuropsychology 2005; 19: 390-402.
Schulz KP, Newcorn JH, Fan J, Tang CY, Halperin JM. Brain activation gradients in ventrolateral prefrontal cortex related to persistence of ADHD in adolescent boys. Journal of the American Academy of Child and Adolescent Psychiatry 2005; 44: 47-54.
Schulz KP, Fan J, Tang CY, Newcorn JH, Buchsbaum MS, Cheung AM, Halperin JM. Response inhibition in adolescents diagnosed with attention-deficit/ hyperactivity disorder during childhood: An event-related fMRI study. American Journal of Psychiatry 2004; 161: 1650-1657.
Halperin JM, Schulz KP, McKay KE, Sharma V, Newcorn JH. Familial correlates of central serotonin function in children with disruptive behavior disorders. Psychiatry Research 2003; 119: 205-216.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Schulz did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
1425 Madison Avenue
Room 6-40
New York, NY 10029
Fax: 212-649-1290
